Skip to main content
IX BIOPHARMA LTD. logo

IX BIOPHARMA LTD. — Investor Relations & Filings

Ticker · 42C ISIN · SG1BD9000009 SGX Manufacturing
Filings indexed 41 across all filing types
Latest filing 2026-03-13 Regulatory Filings
Country SG Singapore
Listing SGX 42C

About IX BIOPHARMA LTD.

https://www.ixbiopharma.com/

IX Biopharma Ltd. is a specialty pharmaceutical and nutraceutical company focused on developing and commercializing innovative therapies. Leveraging its proprietary WaferiX sublingual drug delivery technology, the company aims to improve the quality of life for patients with pain, chronic diseases, and debilitating conditions, particularly those affecting the central nervous system. A key product is Wafermine, a sublingual ketamine wafer designed for rapid, non-opioid relief of acute moderate to severe pain. The company was recently awarded a US$41 million U.S. government contract to fund Wafermine's Phase 3 clinical development and secure FDA Emergency Use Authorization. Additionally, iX Biopharma offers nutraceutical products, such as a sublingual NAD+ wafer for cellular energy production.

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.